ESO Eastern Europe and Balkan Region Refresher Course on Gastrointestinal Cancer
B

Optimal Management of Liver Metastatic Colorectal Cancer: Combining Different Treatment Modalities Provides Better Disease Control

By ESO Eastern Europe and Balkan Region Refresher Course on Gastrointestinal Cancer FEATURING Borislav Belev
By ESO Eastern Europe and Balkan Region Refresher Course on Gastrointestinal Cancer FEATURING Borislav Belev
0 views
November 28, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

10:25
Exelixis

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Featured Video

20:00
Exelixis

Child-Pugh Classification and its Role in Treatment Decisions in Pat…

Feat. P. Gholam

Recommended

AUTOPLAY
23:58
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Key Studies

Feat. R. Kim, R. Mehta
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

Feat. V. Subbiah
15:51
Total Health

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Feat. A. Grothey
13:29
Ibrahim Sahin

Treating KRAS-Mutated mCRC

09:25
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Expert Panel Discussion on CRC Including T…

Feat. N. Uboha, K. Spencer, M. Cecchini
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
18:02
Ibrahim Sahin

Treating HER2-Amplified mCRC

11:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase III FIRE-4 Study - Influence of Bas…

Feat. S. Stintzing
15:56
Van Morris

ASCO Updated Guidelines for the Treatment of Metastatic Colorectal C…

Feat. C. Eng
18:23
Ibrahim Sahin

Treating BRAF-Mutated mCRC

07:16
Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Panel Discussion: "CheckMate-8HW Clinical Implica…

Feat. Y. Janjigian, S. Cytryn, S. Klempner
06:51
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "PanaMa Trial - FU/FA Maintenance Therapy …

Feat. D. Modest
16:39
UChicago Medicine

Treatment of mCRC After Standard Chemotherapy

Feat. A. Shergill
06:26
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "64-Month Follow-Up From CheckMate 142 - 1…

Feat. H. Lenz
18:34
Total Health

Management of Colorectal Liver Metastases

Feat. S. Gholami
21:24
Fred Hutchinson Cancer Center

Re-Challenge With Systemic Therapy for mCRC

Feat. R. Hsieh
25:57
Northwestern Medicine Oncology and Hematology

ASCO®, ESMO, and NCCN Guidelines on Treatment and Biomarker Testing/…

Feat. A. Benson
26:51
EAO-CRC Summit 2024

Optimal Management of CRC Liver Metastases

Feat. M. Montenovo
06:05
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Results From the GALAXY Study in …

Feat. E. Oki
05:18
Benjamin Weinberg

EGFR Targeted Therapy for mCRC: Differences Between Cetuximab and Pa…